University of Georgia vaccine protects against multiple fungal infections while preserving gut microbiome

University of Georgia scientists have announced that a novel vaccine designed to protect against several life‑threatening fungal infections has successfully induced protective immunity in preclinical animal studies. The findings, reported in the journal *Microbiology Spectrum*, demonstrate that the vaccine elicits a robust immune response while preserving the diversity of the gut microbiome in the test subjects.

The research team engineered the vaccine to target multiple pathogenic fungi that pose significant risks to immunocompromised patients and those undergoing invasive medical procedures. In animal models, vaccinated subjects showed marked resistance to fungal challenge, with reduced fungal burden and improved survival rates. Importantly, microbiome analysis revealed no significant disruption of gut bacterial diversity, suggesting that the vaccine does not compromise the host’s microbial ecosystem.

These results represent a promising step toward a broadly protective antifungal immunization strategy. Further studies are required to evaluate safety and efficacy in humans, but the preservation of gut microbiome integrity is a critical factor that may facilitate future clinical development.